Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • EUROPE CONTRAST ENHANCED ULTRASOUND MARKET FORECAST 2022-2030

EUROPE CONTRAST ENHANCED ULTRASOUND MARKET FORECAST 2022-2030

The Europe contrast enhanced ultrasound market is predicted to register a CAGR of 5.28% during the forecast period, 2022-2030, and is set to reach a revenue of $769.27 million by 2030.

EUROPE CONTRAST ENHANCED ULTRASOUND MARKET FORECAST 2022-2030

Europe Contrast Enhanced Ultrasound Market by Product (Equipment, Contrast Agent) Market by Type (Non-targeted, Targeted) Market by End-user (Hospitals, Clinics, Ambulatory Diagnostic Centers) by Geography

Request free sample

The Europe contrast enhanced ultrasound market is predicted to register a CAGR of 5.28% during the forecast period, 2022-2030, and is set to reach a revenue of $769.27 million by 2030.

The contrast enhanced ultrasound market growth in Europe is attributed to the new applications of contrast enhanced ultrasound technology and the increasing number of associated procedures in accordance with the published guidelines by the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB).

Europe Contrast Enhanced Ultrasound Market

To know more about this report, request a free sample copy

In addition, the countries in the region encompass robust healthcare provisions that facilitate easy access to healthcare, including ultrasound imaging, thereby offering growth opportunities for the analyzed market. However, the market growth is restrained by the allergy concerns like angioedema, bronchospasm, hives, vomiting, etc., in response to contrast agents.

The Europe contrast enhanced ultrasound market growth assessment includes the analysis of the United Kingdom, Nordic Countries, Spain, Italy, France, Germany, and Rest of Europe. In the United Kingdom, the market growth is accredited to the wide use of contrast enhanced ultrasound technology over conventional ultrasonography. Also, the rising number of ultrasound procedures is attributed to the growing availability of effective reimbursement schemes and the increasing burden of chronic diseases. For instance, the growing prevalence of gastrointestinal and cardiovascular disorders. As per the UK government stats, 17 million individuals are diagnosed with gastrointestinal infections annually.

Further, in Spain, the trend of ultrasonography utilization in routine primary care is projected to increase market growth. Also, the rising acceptance of contrast enhanced ultrasonography in the country is ascribed to its efficiency. In addition, the Spanish Federation of Societies for Ultrasound in Medicine and Biology and the European Society of Radiology are offering comprehensive training programs and teaching tools associated with the use of ultrasound devices. Besides, the country has greater access to in-office ultrasound exams in primary care compared to countries with higher healthcare expenditures. Moreover, the rising cardiovascular and digestive disorders are anticipated to increase the use of contrast enhanced ultrasonography, thereby offering growth opportunities.

The Europe contrast enhanced ultrasound market segmentation entails end-user, type, and product. The end-user segment includes ambulatory diagnostic centers, clinics, and hospitals.

The rural patients lack proper access to CT/MRI imaging facilities, leaving several cases undetected. Accordingly, NGOs and government organizations are taking appropriate responses, like setting up mobile camps to cover such locations. Also, there is an emerging trend of providing medical imaging services in developing and developed countries. Ultrasound is one of the main tools used in conjunction with mobile units, given its benefits like diagnostic efficiency, vast clinical use, cost, and portability. Therefore, ambulatory diagnostic centers are projected to witness increased demands for ultrasound contrast agents due to the growing volume of ultrasound procedures.

Some of the prominent companies operating in the Europe contrast enhanced ultrasound market include Taejoon Pharm, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co Ltd, Trivitron Healthcare, etc.

Siemens Healthineers AG provides healthcare solutions and services globally. It operates through three business segments, advanced therapies, imaging, and diagnostics. The imaging segment provides equipment like molecular imaging, ultrasound, X-ray systems, magnetic resonance, and computed tomography. In addition, the company offers AI-powered imaging solutions to raise the efficiency of imaging procedures. The company has its headquarters in Erlangen, Germany.

One of its key products, Acuson Juniper 2.02, is an ultrasound system with the new 6C1 single crystal transducer equipped with liver elastography and contrast enhanced ultrasound (CEUS).

Report Synopsis

Report Scope

Details
Market Forecast Years 2022-2030
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue ($ Million)
Segments Analyzed End-User, Type, Product
Countries Analyzed United Kingdom, Nordic Countries, Spain, Italy, France, Germany, and Rest of Europe
Companies Analyzed

GE Healthcare, Bracco Diagnostic Inc, Trivitron Healthcare Pvt Ltd, Koninklijke Philips NV, Daiichi Sankyo Company, Limited, Siemens Healthineers AG, Lantheus Medical Imaging, Inc, Shenzhen Mindray Bio-Medical Electronics Co Ltd, NanoPET Pharma GmbH, Bayer AG, Taejoon Pharm Co Ltd, Sanochemia Pharmazeutika GmbH

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • SURGING PREVALENCE OF CHRONIC DISEASES
        • HEALTH PRACTITIONERS PREFER CONTRAST ENHANCED ULTRASOUND IMAGING
        • TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSIS
      • KEY RESTRAINTS
        • NON-UNIFORMITY OF CONTRAST AGENTS
        • DIFFICULTY IN ADOPTION IN THE CURRENT HEALTHCARE SYSTEM
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON CONTRAST ENHANCED ULTRASOUND MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • VALUE CHAIN ANALYSIS
      • KEY BUYING CRITERIA
        • COST EFFICIENCY
        • PRODUCT FEATURES
        • END-USE
      • REGULATORY FRAMEWORK
    2. MARKET BY PRODUCT
      • EQUIPMENT
      • CONTRAST AGENT
    3. MARKET BY TYPE
      • NON-TARGETED
      • TARGETED
    4. MARKET BY END-USER
      • HOSPITALS
      • CLINICS
      • AMBULATORY DIAGNOSTIC CENTERS
    5. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • SPAIN
          • NORDIC COUNTRIES
          • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS & DIVESTITURES
      • COMPANY PROFILES
        • BAYER AG
        • BRACCO DIAGNOSTIC INC
        • DAIICHI SANKYO COMPANY LIMITED
        • GE HEALTHCARE
        • KONINKLIJKE PHILIPS NV
        • LANTHEUS MEDICAL IMAGING INC
        • NANOPET PHARMA GMBH
        • SANOCHEMIA PHARMAZEUTIKA GMBH
        • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
        • SIEMENS HEALTHINEERS AG
        • TAEJOON PHARM
        • TRIVITRON HEALTHCARE

    LIST OF TABLES

    TABLE 1: EUROPE MARKET SNAPSHOT – CONTRAST ENHANCED ULTRASOUND

    TABLE 2: EXAMPLES OF CURRENT CLINICAL ULTRASOUND CONTRAST AGENTS

    TABLE 3: EXAMPLES OF EMERGING ULTRASOUND MICROBUBBLES-BASED TECHNIQUES

    TABLE 4: REGULATORY FRAMEWORK

    TABLE 5: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 6: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 7: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 8: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 9: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 10: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 11: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 12: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 13: LEADING PLAYERS OPERATING IN EUROPE CONTRAST ENHANCED ULTRASOUND MARKET

    TABLE 14: LIST OF MERGERS & ACQUISITIONS

    TABLE 15: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 16: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 17: LIST OF BUSINESS EXPANSIONS & DIVESTITURES   

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: VALUE CHAIN ANALYSIS

    FIGURE 6: KEY BUYING CRITERIA

    FIGURE 7: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021

    FIGURE 8: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY EQUIPMENT, 2022-2030 (IN $ MILLION)

    FIGURE 9: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY CONTRAST AGENT, 2022-2030 (IN $ MILLION)

    FIGURE 10: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021

    FIGURE 11: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY NON-TARGETED, 2022-2030 (IN $ MILLION)

    FIGURE 12: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY TARGETED, 2022-2030 (IN $ MILLION)

    FIGURE 13: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021

    FIGURE 14: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY HOSPITALS, 2022-2030 (IN $ MILLION)

    FIGURE 15: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY CLINICS, 2022-2030 (IN $ MILLION)

    FIGURE 16: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY AMBULATORY DIAGNOSTIC CENTERS, 2022-2030 (IN $ MILLION)

    FIGURE 17: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

    FIGURE 18: UNITED KINGDOM CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 19: GERMANY CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 20: FRANCE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 21: ITALY CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 22: SPAIN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 23: NORDIC COUNTRIES CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 24: REST OF EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)       

    1. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • SPAIN
          • NORDIC COUNTRIES
          • REST OF EUROPE
    1. MARKET BY PRODUCT
      • EQUIPMENT
      • CONTRAST AGENT
    2. MARKET BY TYPE
      • NON-TARGETED
      • TARGETED
    3. MARKET BY END-USER
      • HOSPITALS
      • CLINICS
      • AMBULATORY DIAGNOSTIC CENTERS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type